GNPX
Price
$0.23
Change
-$0.02 (-8.00%)
Updated
Jun 25, 04:59 PM (EDT)
Capitalization
6.56M
HOWL
Price
$1.20
Change
-$0.05 (-4.00%)
Updated
Jun 25, 04:59 PM (EDT)
Capitalization
53.62M
42 days until earnings call
Interact to see
Advertisement

GNPX vs HOWL

Header iconGNPX vs HOWL Comparison
Open Charts GNPX vs HOWLBanner chart's image
Genprex
Price$0.23
Change-$0.02 (-8.00%)
Volume$27.2K
Capitalization6.56M
Werewolf Therapeutics
Price$1.20
Change-$0.05 (-4.00%)
Volume$12.98K
Capitalization53.62M
GNPX vs HOWL Comparison Chart in %
Loading...
GNPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HOWL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GNPX vs. HOWL commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNPX is a Buy and HOWL is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (GNPX: $0.25 vs. HOWL: $1.25)
Brand notoriety: GNPX and HOWL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNPX: 176% vs. HOWL: 0%
Market capitalization -- GNPX: $6.56M vs. HOWL: $53.62M
GNPX [@Biotechnology] is valued at $6.56M. HOWL’s [@Biotechnology] market capitalization is $53.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $312.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNPX’s FA Score shows that 0 FA rating(s) are green whileHOWL’s FA Score has 0 green FA rating(s).

  • GNPX’s FA Score: 0 green, 5 red.
  • HOWL’s FA Score: 0 green, 5 red.
According to our system of comparison, HOWL is a better buy in the long-term than GNPX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNPX’s TA Score shows that 4 TA indicator(s) are bullish while HOWL’s TA Score has 3 bullish TA indicator(s).

  • GNPX’s TA Score: 4 bullish, 4 bearish.
  • HOWL’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, GNPX is a better buy in the short-term than HOWL.

Price Growth

GNPX (@Biotechnology) experienced а -16.67% price change this week, while HOWL (@Biotechnology) price change was +3.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.95%. For the same industry, the average monthly price growth was +32.23%, and the average quarterly price growth was +16.56%.

Reported Earning Dates

GNPX is expected to report earnings on Apr 01, 2025.

HOWL is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+1.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HOWL($53.6M) has a higher market cap than GNPX($6.56M). HOWL YTD gains are higher at: -15.541 vs. GNPX (-70.643). GNPX has higher annual earnings (EBITDA): -19.14M vs. HOWL (-65.72M). HOWL has more cash in the bank: 92M vs. GNPX (3.47M). GNPX has less debt than HOWL: GNPX (279K) vs HOWL (37M). HOWL has higher revenues than GNPX: HOWL (1.14M) vs GNPX (0).
GNPXHOWLGNPX / HOWL
Capitalization6.56M53.6M12%
EBITDA-19.14M-65.72M29%
Gain YTD-70.643-15.541455%
P/E RatioN/AN/A-
Revenue01.14M-
Total Cash3.47M92M4%
Total Debt279K37M1%
FUNDAMENTALS RATINGS
GNPX: Fundamental Ratings
GNPX
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GNPXHOWL
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 16 days ago
79%
Bullish Trend 28 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 15 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
GNPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HOWL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRWS3.200.16
+5.26%
Crown Crafts
XPEL36.380.26
+0.72%
XPEL
LCID2.170.01
+0.46%
Lucid Group
T28.280.08
+0.28%
AT&T
ORN8.86N/A
N/A
Orion Group Holdings

GNPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GNPX has been loosely correlated with REVB. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if GNPX jumps, then REVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNPX
1D Price
Change %
GNPX100%
+9.17%
REVB - GNPX
48%
Loosely correlated
+12.40%
HOWL - GNPX
37%
Loosely correlated
N/A
AXON - GNPX
30%
Poorly correlated
+1.41%
TYRA - GNPX
30%
Poorly correlated
+0.31%
APVO - GNPX
30%
Poorly correlated
+6.46%
More

HOWL and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOWL has been loosely correlated with IPSC. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if HOWL jumps, then IPSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOWL
1D Price
Change %
HOWL100%
N/A
IPSC - HOWL
44%
Loosely correlated
+3.39%
GBIO - HOWL
44%
Loosely correlated
+2.89%
ARCT - HOWL
43%
Loosely correlated
+7.19%
CLDX - HOWL
41%
Loosely correlated
+6.18%
ABOS - HOWL
41%
Loosely correlated
+2.44%
More